JNK2 (MAPK9) (NM_002752) Human Recombinant Protein
CAT#: TP312814
Recombinant protein of human mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-a2
Specifications
Product Data | |
Species | Human |
Expression Host | HEK293T |
Expression cDNA Clone or AA Sequence |
Recombinant protein was produced with TrueORF clone, RC212814. Click on the TrueORF clone link to view cDNA and protein sequences.
|
Tag | C-Myc/DDK |
Predicted MW | 48 kDa |
Concentration | >50 ug/mL as determined by microplate BCA method |
Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol |
Preparation | Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps. |
Storage | Store at -80°C. |
Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Reference Data | |
RefSeq | NP_002743 |
Locus ID | 5601 |
UniProt ID | P45984 |
Cytogenetics | 5q35.3 |
Refseq Size | 1942 |
Refseq ORF | 1272 |
Synonyms | JNK-55; JNK2; JNK2A; JNK2ALPHA; JNK2B; JNK2BETA; p54a; p54aSAPK; PRKM9; SAPK; SAPK1a |
Summary | 'The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase targets specific transcription factors, and thus mediates immediate-early gene expression in response to various cell stimuli. It is most closely related to MAPK8, both of which are involved in UV radiation induced apoptosis, thought to be related to the cytochrome c-mediated cell death pathway. This gene and MAPK8 are also known as c-Jun N-terminal kinases. This kinase blocks the ubiquitination of tumor suppressor p53, and thus it increases the stability of p53 in nonstressed cells. Studies of this gene's mouse counterpart suggest a key role in T-cell differentiation. Several alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Sep 2008]' |
Protein Families | Druggable Genome, ES Cell Differentiation/IPS, Protein Kinase |
Protein Pathways | Adipocytokine signaling pathway, Colorectal cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Fc epsilon RI signaling pathway, Focal adhesion, GnRH signaling pathway, Insulin signaling pathway, MAPK signaling pathway, Neurotrophin signaling pathway, NOD-like receptor signaling pathway, Pancreatic cancer, Pathways in cancer, Progesterone-mediated oocyte maturation, RIG-I-like receptor signaling pathway, T cell receptor signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, Wnt signaling pathway |
Documents
FAQs |
SDS |
Resources
Recombinant Protein Resources |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
LC400972 | MAPK9 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LC408411 | MAPK9 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LC408412 | MAPK9 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LC408413 | MAPK9 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 187.00 |
|
LC430090 | MAPK9 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LY400972 | Transient overexpression lysate of mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-a2 |
USD 396.00 |
|
LY408411 | Transient overexpression lysate of mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-a1 |
USD 396.00 |
|
LY408412 | Transient overexpression lysate of mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-b1 |
USD 396.00 |
|
LY408413 | Transient overexpression lysate of mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-b2 |
USD 605.00 |
|
LY430090 | Transient overexpression lysate of mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-b1 |
USD 396.00 |
|
PH307608 | MAPK9 MS Standard C13 and N15-labeled recombinant protein (NP_620707) |
USD 2,055.00 |
|
PH312273 | MAPK9 MS Standard C13 and N15-labeled recombinant protein (NP_620709) |
USD 2,055.00 |
|
PH312814 | MAPK9 MS Standard C13 and N15-labeled recombinant protein (NP_002743) |
USD 2,055.00 |
|
TP307608 | Recombinant protein of human mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-a1 |
USD 867.00 |
|
TP312273 | Recombinant protein of human mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-b2 |
USD 823.00 |
|
TP761541 | Purified recombinant protein of Human mitogen-activated protein kinase 9 (MAPK9), transcript variant JNK2-b1, full length, with N-terminal HIS tag, expressed in E. coli, 50ug |
USD 215.00 |
{0} Product Review(s)
Be the first one to submit a review